Wang Chenjing, Liu Juntian, Guo Fang, Ji Yuanyuan, Liu Na
Department of Pharmacology, Xi'an Jiaotong University School of Medicine, Xi'an, PR China.
Biochem Biophys Res Commun. 2009 Nov 20;389(3):537-42. doi: 10.1016/j.bbrc.2009.09.023. Epub 2009 Sep 11.
Numerous studies have shown that both vasoconstrictive peptide endothelin-1 (ET-1) and inflammatory marker C-reactive protein (CRP) are implicated in the inflammatory process of atherosclerosis. The purpose of the present study was to observe effect of ET-1 on CRP production and the molecular mechanisms in rat vascular smooth muscle cells (VSMCs). The results showed that ET-1 was capable of stimulating VSMCs to produce CRP both in protein and in mRNA levels in vitro and in vivo. ET(A) receptor antagonist BQ123, but not ET(B) receptor antagonist BQ788, inhibited CRP production in VSMCs. In addition, ET-1 was able to elicit reactive oxygen species (ROS) generation and mitogen-activated protein kinase (MAPK) activation, and antioxidant pyrrolidine dithiocarbamate and p38MAPK inhibitor SB203580 inhibited ET-1-induced CRP expression. The results demonstrate that ET-1 induces CPR production in VSMCs via ET(A) receptor followed by ROS and MAPK signal pathway, which may contribute to better understanding of the role of ET-1 in inflammatory activation of the vessel wall during atherogenesis.
大量研究表明,血管收缩肽内皮素 -1(ET-1)和炎症标志物C反应蛋白(CRP)均参与动脉粥样硬化的炎症过程。本研究的目的是观察ET-1对大鼠血管平滑肌细胞(VSMC)中CRP产生的影响及其分子机制。结果表明,ET-1在体外和体内均能刺激VSMC产生蛋白质和mRNA水平的CRP。ET(A)受体拮抗剂BQ123可抑制VSMC中CRP的产生,而ET(B)受体拮抗剂BQ788则无此作用。此外,ET-1能够引发活性氧(ROS)生成和丝裂原活化蛋白激酶(MAPK)激活,抗氧化剂吡咯烷二硫代氨基甲酸盐和p38MAPK抑制剂SB203580可抑制ET-1诱导的CRP表达。结果表明,ET-1通过ET(A)受体,继之通过ROS和MAPK信号通路诱导VSMC中CPR的产生,这可能有助于更好地理解ET-1在动脉粥样硬化形成过程中血管壁炎症激活中的作用。